scholarly article | Q13442814 |
P50 | author | Rolf H Sijmons | Q43117829 |
Amanda Spurdle | Q45904058 | ||
Maurizio Genuardi | Q55414619 | ||
William David Foulkes | Q37829195 | ||
Robert Hofstra | Q43097735 | ||
P2093 | author name string | Lawrence C Brody | |
Olga Sinilnikova | |||
Sharon E Plon | |||
IARC Unclassified Genetic Variants Working Group | |||
Marc S Greenblatt | |||
Magali Olivier | |||
P2860 | cites work | A survey of locus-specific database curation. Human Genome Variation Society | Q43232350 |
Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). | Q44498341 | ||
Recommendations of the 2006 Human Variome Project meeting | Q44742265 | ||
Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations | Q47577422 | ||
Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group | Q48771295 | ||
A structured simple form for ordering genetic tests is needed to ensure coupling of clinical detail (phenotype) with DNA variants (genotype) to ensure utility in publication and databases | Q50146740 | ||
BI-RADS classification for management of abnormal mammograms | Q53602659 | ||
Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants | Q56900472 | ||
Genetic and Histopathologic Evaluation ofBRCA1andBRCA2DNA Sequence Variants of Unknown Clinical Significance | Q57306006 | ||
Clinical Classification ofBRCA1andBRCA2DNA Sequence Variants: The Value of Cytokeratin Profiles and Evolutionary Analysis—A Report From the kConFab Investigators | Q57306048 | ||
Analysis of published PKD1 gene sequence variants | Q59416415 | ||
Locus-specific mutation databases: pitfalls and good practice based on the p53 experience | Q59526197 | ||
Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer | Q61946741 | ||
Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core | Q71532382 | ||
Cancer risk assessment at the atomic level | Q82606196 | ||
Recommendations for locus-specific databases and their curation | Q24646762 | ||
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database | Q29616468 | ||
Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR). | Q30360539 | ||
Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. | Q30432624 | ||
The breast cancer information core: database design, structure, and scope | Q30482109 | ||
Genetic evidence and integration of various data sources for classifying uncertain variants into a single model | Q33379396 | ||
Prediction and assessment of splicing alterations: implications for clinical testing | Q33704900 | ||
Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2 | Q33910123 | ||
Time for a unified system of mutation description and reporting: a review of locus-specific mutation databases | Q34127341 | ||
Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance. | Q34252077 | ||
Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts | Q34286570 | ||
Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. | Q34713545 | ||
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results | Q34788325 | ||
Database of p53 gene somatic mutations in human tumors and cell lines | Q34868968 | ||
Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC/INSiGHT mutation database | Q35940640 | ||
In silico analysis of missense substitutions using sequence-alignment based methods | Q36200498 | ||
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes | Q36492194 | ||
Functional analysis helps to clarify the clinical importance of unclassified variants in DNA mismatch repair genes | Q36862037 | ||
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral | Q36927199 | ||
Assessment of functional effects of unclassified genetic variants | Q37308298 | ||
Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation. | Q38301022 | ||
Use of the American College of Radiology BI-RADS guidelines by community radiologists: concordance of assessments and recommendations assigned to screening mammograms | Q39606096 | ||
The CDKN2A database: Integrating allelic variants with evolution, structure, function, and disease association | Q40483208 | ||
P433 | issue | 11 | |
P304 | page(s) | 1273-1281 | |
P577 | publication date | 2008-11-01 | |
P1433 | published in | Human Mutation | Q5937269 |
P1476 | title | Locus-specific databases and recommendations to strengthen their contribution to the classification of variants in cancer susceptibility genes | |
P478 | volume | 29 |
Q57200486 | A database to support the interpretation of human mismatch repair gene variants |
Q34961153 | Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database |
Q42394236 | Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group |
Q37308298 | Assessment of functional effects of unclassified genetic variants |
Q39012719 | CDKN2A unclassified variants in familial malignant melanoma: combining functional and computational approaches for their assessment. |
Q90315966 | Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network |
Q54364278 | Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. |
Q50728624 | Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory |
Q89317557 | Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants |
Q38484600 | DRUMS: a human disease related unique gene mutation search engine |
Q37460645 | Interpreting secondary cardiac disease variants in an exome cohort |
Q30484637 | Leiden Open Variation Database of the MUTYH gene |
Q93361002 | Lessons learned from two decades of BRCA1 and BRCA2 genetic testing: the evolution of data sharing and variant classification |
Q28744635 | Practical guidelines addressing ethical issues pertaining to the curation of human locus-specific variation databases (LSDBs) |
Q33704900 | Prediction and assessment of splicing alterations: implications for clinical testing |
Q30401706 | Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed |
Q36096070 | Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility Genes |
Q34788325 | Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results |
Q37334266 | The Clinical Significance of Unknown Sequence Variants in BRCA Genes. |
Q38857623 | Tools for Predicting the Functional Impact of Nonsynonymous Genetic Variation |
Q34252077 | Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance. |
Q43937975 | UMD-CFTR: a database dedicated to CF and CFTR-related disorders |
Q30689554 | Using exome data to identify malignant hyperthermia susceptibility mutations |
Search more.